CN214807350U - Double-cavity infusion port implanted drug delivery device - Google Patents
Double-cavity infusion port implanted drug delivery device Download PDFInfo
- Publication number
- CN214807350U CN214807350U CN202022890767.XU CN202022890767U CN214807350U CN 214807350 U CN214807350 U CN 214807350U CN 202022890767 U CN202022890767 U CN 202022890767U CN 214807350 U CN214807350 U CN 214807350U
- Authority
- CN
- China
- Prior art keywords
- double
- infusion tube
- cavity
- main
- auxiliary
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Landscapes
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
本实用新型公开了一种双腔输液港植入式给药装置，该给药装置创新性的将传统的单孔针设计成的双腔针，并设计了与双腔针相接的双腔导管，以及在双腔导管的分叉处安装了分叉头，在分叉头上分别安装了左排气阀和右排气阀，以及在分叉头后端分别连接了主输液管和副输液管，主输液管和副输液管的末端分别连接了主管接头和副管接头，在主输液管和副输液管上分别安装了一个主管夹和副管夹，该装置解决了当前病人病情严重抢救时，急需快速补液，且同时需要用血管活性药时，要开通多通道的问题；该装置能直接输入常规和血管活性药，非常方便实用，同时，该装置平常也可作为多通道液体输注装置，减少了病人的多次穿刺痛苦，具有非常积极的实际应用价值。
The utility model discloses a double-chamber infusion port implantable drug delivery device. The drug delivery device innovatively designs a traditional single-hole needle into a double-chamber needle, and designs a double-chamber needle connected with the double-chamber needle. The catheter, and the bifurcation head is installed at the bifurcation of the double lumen catheter, the left exhaust valve and the right exhaust valve are respectively installed on the bifurcation head, and the main infusion pipe and the auxiliary infusion pipe are respectively connected to the rear end of the bifurcation head The end of the infusion tube, the main infusion tube and the auxiliary infusion tube are connected with the main tube connector and the sub-infusion tube respectively, and a main infusion tube and a sub-infusion tube are installed on the main infusion tube and the sub-infusion tube respectively. During rescue, rapid rehydration is urgently needed, and when vasoactive drugs are needed at the same time, it is necessary to open multiple channels; the device can directly input conventional and vasoactive drugs, which is very convenient and practical. The injection device reduces the pain of multiple punctures for patients, and has very positive practical application value.
Description
Technical Field
The utility model relates to the technical field of medical equipment, concretely relates to two-chamber infusion port implanted device of dosing.
Background
Clinically, when a patient is seriously in need of rescue, the patient needs to be quickly replenished with liquid, and vasoactive drugs need to be used, the patient needs to be provided with a plurality of channels, but the existing drug delivery device generally adopts a single-base infusion port which only has a single channel to use, the single-channel liquid infusion mode adopts a single-channel liquid infusion mode, if the blood vessel condition of the patient is not good, the infusion port can only be connected with a plurality of tee joints, the mode can lead to no quick liquid infusion during rescue, especially when the vasoactive drugs are used, the non-uniform liquid has large influence on the drug speed, the stabilization of the vital signs of the patient is not convenient, in order to solve the problem, the utility model provides a drug delivery device which can use a double-cavity infusion port, adopts a mode of drug delivery by the double-cavity infusion port, and can avoid the patient from being provided with a plurality of channels, the puncture device reduces repeated venipuncture, relieves puncture pain of patients, can accurately use vasoactive drugs, reduces the length of single-cavity three-way connection, can effectively improve the medical effect, and has very positive practical significance.
SUMMERY OF THE UTILITY MODEL
Aiming at the defects of the prior art, the utility model aims at providing a double-cavity infusion port implanted type drug delivery device.
In order to achieve the above purpose, the utility model adopts the following technical scheme:
a double-cavity infusion port implanted drug delivery device comprises a double-cavity needle, needle wings, a double-cavity catheter, a branching head, a left exhaust valve, a right exhaust valve, a main infusion tube, a main tube connector, a main tube clamp, an auxiliary infusion tube, an auxiliary tube connector and an auxiliary tube clamp, wherein the inside of the double-cavity needle is of a double-cavity structure, the double-cavity needle is vertically connected with the needle wings, the inside of the double-cavity catheter is of a double-cavity pipeline structure, the double-cavity catheter is fixedly connected with the double-cavity needle, double-cavity pipelines inside the double-cavity catheter are respectively communicated with the double-cavity structure inside the double-cavity needle, one end of the branching head is fixedly connected with the double-cavity catheter, the other end of the branching head is respectively connected with the main infusion tube and the auxiliary infusion tube, the main infusion tube and the auxiliary infusion tube are respectively communicated with a single pipeline of the double-cavity catheter, the left exhaust valve and the right exhaust valve are respectively installed on the branching head, the inside of the left exhaust valve is communicated with the inside of the auxiliary infusion tube, and the right exhaust valve is communicated with the main infusion tube, the main pipe joint is arranged at the tail end of the main infusion pipe, the auxiliary pipe joint is arranged at the tail end of the auxiliary infusion pipe, and the main pipe clamp and the auxiliary pipe clamp are respectively arranged on the main infusion pipe and the auxiliary infusion pipe.
The utility model discloses following beneficial effect has: in order to realize the quick fluid infusion for patients, the administration device designs the traditional single-hole needle into a double-cavity needle with two channels, designs the guide rail of the traditional channel into a double-cavity catheter, simultaneously installs a bifurcation head at the bifurcation of the double-cavity catheter, and installs a left exhaust valve and a right exhaust valve at the left and right sides of the bifurcation head in order to avoid the too high pressure intensity or the air pressure difference in the pipeline for the convenient and quick fluid infusion; in addition, in order to facilitate fluid infusion, the rear end of the bifurcate head is respectively connected with a main infusion tube with a thicker cavity and an auxiliary infusion tube with a thinner cavity, when the device is used, the main infusion tube with the thicker cavity is used for inputting conventional liquid and is used when speed is not controlled or rapid infusion is needed, and the auxiliary infusion tube with the thinner cavity is used when drugs with accurate speed control, such as vasoactive drugs, are input; the tail ends of the main infusion tube and the auxiliary infusion tube are respectively connected with a main tube joint and an auxiliary tube joint, a main tube clamp and an auxiliary tube clamp are respectively arranged on the main infusion tube and the auxiliary infusion tube, and the main tube clamp and the auxiliary tube clamp are used for respectively closing the main infusion tube and the auxiliary infusion tube. The device can realize that when a patient needs quick fluid infusion and vasoactive drugs are carried out simultaneously, repeated venipuncture can be reduced, a plurality of channels are avoided being opened, the rescue speed of the patient is improved, and the device is very practical and convenient. Meanwhile, the device can be used for multi-channel liquid infusion at ordinary times, so that the puncture pain of a patient is reduced, and the device has very practical application and popularization values.
Drawings
Fig. 1 is a schematic view of the overall structure of the double-chamber infusion port implanted drug delivery device of the present invention;
fig. 2 is a schematic view of the overall structure of the dual-chamber infusion port implantable drug delivery device of the present invention in the top view direction;
FIG. 3 is a schematic diagram of the internal structure of the double lumen catheter portion of the double lumen infusion port implantable drug delivery device of the present invention;
fig. 4 is a schematic cross-sectional view of a double-lumen needle of the double-lumen infusion port implantable drug delivery device of the present invention;
fig. 5 is a schematic cross-sectional view of a double-lumen catheter of the double-lumen infusion port implantable drug delivery device of the present invention.
In the figure: 1. a double lumen needle; 2. a needle wing; 3. a double lumen catheter; 4. a forking head; 5. a left exhaust valve; 6. a right exhaust valve; 7. a main infusion tube; 8. a main pipe joint; 9. a main pipe clamp; 10. an auxiliary infusion tube; 11. a secondary pipe joint; 12. and an auxiliary pipe clamp.
Detailed Description
The present invention will be further described with reference to the accompanying drawings and specific embodiments so as to more clearly understand the technical idea claimed in the present invention.
The utility model relates to a double-cavity infusion port implanted drug delivery device as shown in fig. 1 to 5, which comprises a double-cavity needle 1, a needle wing 2, a double-cavity catheter 3, a bifurcation head 4, a left exhaust valve 5, a right exhaust valve 6, a main infusion tube 7, a main tube joint 8, a main tube clamp 9, an auxiliary infusion tube 10, an auxiliary tube joint 11 and an auxiliary tube clamp 12, wherein the inside of the double-cavity needle 1 is of a double-cavity structure, the double-cavity needle 1 is vertically connected with the needle wing 2, the inside of the double-cavity catheter 3 is of a double-cavity pipeline structure, the double-cavity catheter 3 is fixedly connected with the double-cavity needle 1, the double-cavity pipeline inside the double-cavity catheter 3 is respectively communicated with the double-cavity structure inside the double-cavity needle 1, one end of the bifurcation head 4 is fixedly connected with the double-cavity catheter 3, the other end of the bifurcation head 4 is respectively connected with the main infusion tube 7 and the auxiliary infusion tube 10, the main infusion tube 7 and the auxiliary tube 10 are respectively communicated with a single pipeline of the double-cavity catheter 3, the left exhaust valve 5 and the right exhaust valve 6 are respectively installed on the bifurcation head 4, the interior of the left exhaust valve 5 is communicated with the interior of the auxiliary infusion tube 10, the interior of the right exhaust valve 6 is communicated with the main infusion tube 7, the main tube joint 8 is arranged at the tail end of the main infusion tube 7, the auxiliary tube joint 11 is arranged at the tail end of the auxiliary infusion tube 10, and the main tube clamp 9 and the auxiliary tube clamp 12 are respectively arranged on the main infusion tube 7 and the auxiliary infusion tube 10.
Specifically, the outer diameter of the double-lumen needle 1 ranges from 1.5 mm to 1.8 mm. The diameter range of the outer hole of the double-cavity catheter 3 is 2.5-3.5 mm. The diameter range of the inner hole of the main infusion tube 7 is 1.5-2.0mm, and the diameter range of the inner hole of the auxiliary infusion tube 10 is 1.2-1.6 mm.
The utility model discloses a theory of operation does: when the device is used, a main pipe joint 8 and an auxiliary pipe joint 11 of the device are respectively connected with an external medicine input device, if conventional liquid flows into a main infusion pipe 7 through the main pipe joint, medicines with accurately controlled speed and the like flow into an auxiliary infusion pipe 10 through the auxiliary pipe joint 11, the main infusion pipe 7 and the auxiliary infusion pipe 10 both flow into a double-cavity catheter 3 through a branch head 4, the double-cavity structure of the double-cavity catheter 3 is respectively communicated with the main infusion pipe 7 and the auxiliary infusion pipe 10, in order to avoid too high pressure or air pressure difference in the pipelines, a left exhaust valve 5 and a right exhaust valve 6 are arranged on the left side and the right side of the branch head 4, and the air pressure difference between the auxiliary infusion pipe 10 and the main infusion pipe 7 can be reduced by unscrewing the left exhaust valve 5 and the right exhaust valve 6, so that the infusion is convenient; secondly, the double-cavity catheter 3 is communicated with two channels in the double-cavity needle 1, the rear end of the double-cavity needle 1 is vertically connected with the needle wing 2, the needle wing 2 further improves the pressure of the double-cavity needle 1 inserted into an infusion port (the infusion port is buried under the skin, and the prior art is adopted), and when the double-cavity needle 1 is used, the skin and a membrane of the infusion port are punctured under the pressurization of the needle wing 2; finally, in order to facilitate the closing of the infusion line, the device is provided with a main tube clamp 9 and an auxiliary tube clamp 12 respectively on the main infusion tube 7 and the auxiliary infusion tube 10 respectively. The device solves the problems that when the current patient seriously needs to be rescued, rapid fluid infusion is needed, and when vasoactive drugs are needed, a plurality of channels need to be opened, and meanwhile, the device can also be used for infusing the fluid in a common plurality of channels, so that the pain of puncture of the patient is reduced, and the device has very positive practical application and popularization value.
Various other changes and modifications may be made by those skilled in the art based on the above-described technical solutions and concepts, and all such changes and modifications should fall within the scope of the present invention.
Claims (4)
1. A two-chamber infusion port implantation type drug delivery device is characterized in that: comprises a double-cavity needle (1), needle wings (2), a double-cavity catheter (3), a branching head (4), a left exhaust valve (5), a right exhaust valve (6), a main infusion tube (7), a main joint (8), a main clamp (9), an auxiliary infusion tube (10), an auxiliary joint (11) and an auxiliary clamp (12), wherein the inside of the double-cavity needle (1) is of a double-cavity structure, the double-cavity needle (1) is vertically connected with the needle wings (2), the inside of the double-cavity catheter (3) is of a double-cavity pipeline structure, the double-cavity catheter (3) is fixedly connected with the double-cavity needle (1), the double-cavity pipeline inside the double-cavity catheter (3) is respectively communicated with the double-cavity structure inside the double-cavity needle (1), one end of the branching head (4) is fixedly connected with the double-cavity catheter (3), the other end of the branching head (4) is respectively connected with the main infusion tube (7) and the auxiliary infusion tube (10), the main infusion tube (7) and the auxiliary infusion tube (10) are respectively communicated with a single pipeline of the double-cavity catheter (3), a left exhaust valve (5) and a right exhaust valve (6) are respectively arranged on a bifurcation head (4), the inside of the left exhaust valve (5) is communicated with the inside of an auxiliary infusion tube (10), the inside of the right exhaust valve (6) is communicated with a main infusion tube (7), a main tube joint (8) is arranged at the tail end of the main infusion tube (7), an auxiliary tube joint (11) is arranged at the tail end of the auxiliary infusion tube (10), and a main tube clamp (9) and an auxiliary tube clamp (12) are respectively arranged on the main infusion tube (7) and the auxiliary infusion tube (10).
2. The dual lumen access port implantable drug delivery device of claim 1, wherein: the outer diameter of the double-cavity needle (1) ranges from 1.5 mm to 1.8 mm.
3. The dual lumen access port implantable drug delivery device of claim 1, wherein: the diameter range of the outer hole of the double-cavity catheter (3) is 2.5-3.5 mm.
4. The dual lumen access port implantable drug delivery device of claim 1, wherein: the diameter range of the inner hole of the main infusion tube (7) is 1.5-2.0mm, and the diameter range of the inner hole of the auxiliary infusion tube (10) is 1.2-1.6 mm.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202022890767.XU CN214807350U (en) | 2020-12-01 | 2020-12-01 | Double-cavity infusion port implanted drug delivery device |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202022890767.XU CN214807350U (en) | 2020-12-01 | 2020-12-01 | Double-cavity infusion port implanted drug delivery device |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN214807350U true CN214807350U (en) | 2021-11-23 |
Family
ID=78802272
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202022890767.XU Expired - Fee Related CN214807350U (en) | 2020-12-01 | 2020-12-01 | Double-cavity infusion port implanted drug delivery device |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN214807350U (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117731886A (en) * | 2023-12-29 | 2024-03-22 | 中国人民解放军西部战区总医院 | Clinical treatment of oncology is with supplementary device of dosing |
-
2020
- 2020-12-01 CN CN202022890767.XU patent/CN214807350U/en not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117731886A (en) * | 2023-12-29 | 2024-03-22 | 中国人民解放军西部战区总医院 | Clinical treatment of oncology is with supplementary device of dosing |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN203227081U (en) | Implantable intravenous administration device | |
| CN214807350U (en) | Double-cavity infusion port implanted drug delivery device | |
| CN213465006U (en) | Invasive blood pressure monitoring blood sampling device of dosing | |
| CN203001687U (en) | Perfusion connector of disposable indwelling catheter | |
| CN205796117U (en) | Pleuroperitoneal cavity puncture drainage device | |
| CN207768837U (en) | A kind of two-chamber remaining needle | |
| CN105163773B (en) | The pull positive-pressure type medical infusion connector plugged into non small cellCatheter | |
| CN204121527U (en) | A kind of reverse flow resistant indwelling needle | |
| CN107485757A (en) | Novel remaining needle | |
| CN219127887U (en) | Self-fixing central venous transfusion catheter | |
| CN219251117U (en) | Double-cavity intracranial drainage tube | |
| CN205360221U (en) | Isobaric tube clipper of constant volume of two -chamber PICC pipe | |
| CN111166962A (en) | Anticoagulation central venous catheter | |
| CN215135649U (en) | Three-way joint for connecting drainage channel of catheter | |
| CN203525113U (en) | Puncture drainage needle for blood purification | |
| CN215995230U (en) | A new type of multifunctional urinary catheter | |
| CN204815363U (en) | A medical three-way valve | |
| CN217162767U (en) | Remaining needle | |
| CN217660977U (en) | A dual-chamber PICC catheter sealing syringe | |
| CN219558288U (en) | Double-cavity pre-perfusion type central venous catheter flushing and sealing device | |
| CN216148046U (en) | Central venous catheter with closed blood sampling function | |
| CN217472496U (en) | Catheter | |
| CN218890001U (en) | an indwelling needle | |
| CN203493996U (en) | Venous blood collection remaining needle | |
| CN222815842U (en) | A catheter device for delivering liquid medicine into the body |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20211123 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |